Partners and provides cross-functional leadership across Human Resources, Total Rewards, Finance, Tax, Treasury, Legal, Stock Administration, and Information Technology, leveraging payroll expertise to influence enterprise policies, shape business decisions, and drive organizational change; leads payroll workstreams for transactions and other significant business initiatives; and advises senior leadership on payroll strategy, performance, risk, controls, and priorities. The companys diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntingtons disease, classic congenital adrenal hyperplasia, hyperphagia in Prader-Willi syndrome, endometriosis and uterine fibroids , as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas.